TNF and myocarditis: Whether inhibitors of tumor necrosis factor (TNF)-α accelerate or enhance ICI-induced heart failure and myocarditis is currently unknown, as is whether the decreased survival rate is related to an excessive inhibition of immune cell activation against tumor growth or to the negative effects caused by anti-TNF-α therapy itself.